SG
OKUR

StepStone Group’s OnKure Therapeutics OKUR Stock Holding History

StepStone Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Hold
2,660,612
– – 0.56% 6
2026
Q1 		$11M Buy
2,660,612
+2,168,674
+441% +$6.7M 5.31% 4
2025
Q4 		$1.35M Hold
491,938
– – 0.72% 14
2025
Q3 		$1.35M Hold
491,938
– – 0.64% 11
2025
Q2 		$1.18M Hold
491,938
– – 2.33% 9
2025
Q1 		$2.12M Hold
491,938
– – 2.17% 8
2024
Q4 		$4.23M Buy
+491,938
New +$7.45M 3.7% 5

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

StepStone Group's OKUR Position: Q2 2026 in Review

StepStone Group held its OnKure Therapeutics (OKUR) position steady in Q2 2026 at 2,660,612 shares worth $12.1M. The position accounts for 0.56% of the portfolio, ranked #6.

StepStone Group first reported a position in OKUR in Q4 2024 and has held it in 7 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • StepStone Group held 2,660,612 shares of OnKure Therapeutics worth $12.1M as of Q2 2026.
  • StepStone Group left its OnKure Therapeutics share count unchanged in Q2 2026.
  • OnKure Therapeutics made up 0.56% of StepStone Group's portfolio in Q2 2026, its #6 holding.
  • StepStone Group first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on StepStone Group's 13F filing for Q2 2026, filed 13 Aug 2026.